New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 1, 2014
11:18 EDTABBV, JNJAbbVie patents affirmed as invalid by appeals court in suit with J&J unit
An appeals court affirmed a lower court finding that AbbVie (ABBV) patents involving antibodies that are useful for treating diseases are invalid. AbbVie has sued Janssen Biotech, a unit of Johnson & Johnson (JNJ), and Centocor Biologics for infringement of the patent claims. Reference Link
News For ABBV;JNJ From The Last 14 Days
Check below for free stories on ABBV;JNJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 21, 2014
17:03 EDTJNJJohnson & Johnson announces $5B share repurchase program
Johnson & Johnson announced that its board has approved the repurchase of up to $5B of the company's common stock. The company had approximately 2.82B shares of common stock outstanding as of June 29.
17:01 EDTJNJJohnson & Johnson announces $5B share repurchase program
10:27 EDTABBVUBS pharma and federal affairs analysts hold an analyst/industry conference call
Subscribe for More Information
08:01 EDTABBVAbbVie acquisition positive, says Argus
Subscribe for More Information
07:59 EDTABBVShire downgraded to Market Perform from Outperform at Leerink
Leerink downgraded Shire (SHPG) on Friday to Market Perform citing the takeover by AbbVie (ABBV) as it does not expect competitive bids to emerge.
06:43 EDTABBVGrowing market for hepatitis-C treatment prompts legal scramble, WSJ says
Subscribe for More Information
06:10 EDTABBVStocks with implied volatility movement; ABBV JOY
Subscribe for More Information
July 18, 2014
18:04 EDTABBVAbbVie purchase of Shire worth the premium, Barron's reports
Subscribe for More Information
16:47 EDTABBVMarket ends week higher as earnings, M&A offset geopolitical tensions
Subscribe for More Information
13:46 EDTABBVAbbVie price target raised to $85 from $71 at Jefferies
Subscribe for More Information
10:34 EDTABBVShire downgraded to Neutral from Overweight at Piper Jaffray
Shire (SHPG) is being acquired by AbbVie (ABBV).
10:30 EDTABBVAbbVie says can't back out of Shire deal based on tax law change, Bloomberg says
Subscribe for More Information
09:29 EDTABBVAbbVie, Shire says merger should help in enhanced buyback and dividend programs
Subscribe for More Information
05:17 EDTABBVAbbVie, Shire agree on merger worth GBP32B pounds
The boards of AbbVie (ABBV) and Shire (SHPG) announced that they have reached agreement on the terms of a recommended combination of Shire with AbbVie. Under the terms of the Merger, Shire shareholders will be entitled to receive per share GBP 24.44 in cash and 0.8960 new AbbVie shares. Immediately following the transaction, Shire shareholders are expected to hold new AbbVie Shares representing approximately 25% of the issued share capital of new AbbVie. AbbVie expects the transaction to be accretive to adjusted earnings per share in the first year following completion, growing to above $1.00 per share by 2020, with "material ongoing financial and operating benefits." The AbbVie board also expects the transaction to reduce New AbbVie's effective tax rate to approximately 13% by 2016. The Shire board said it "considers the terms of the Transaction to be fair and reasonable." In order to undertake the transaction, AbbVie has formed a new company, New AbbVie, which is incorporated in Jersey, Shire's current place of incorporation. Following completion of the Transaction, New AbbVie will become the holding company of the Shire Group and the AbbVie Group. It is intended that the New AbbVie Shares will be listed on the New York Stock Exchange.
05:12 EDTABBVAbbVie to acquire Shire for 52.48 pounds per share in cash, stock
Subscribe for More Information
July 17, 2014
14:54 EDTJNJJohnson & Johnson weakness creates buying opportunity, says Argus
Subscribe for More Information
12:56 EDTABBVAbbVie set to announce GBP 31B deal to buy Shire, FT says
Subscribe for More Information
12:54 EDTABBVAbbVie set to announce GBP 31B deal to buy Shire, FT says
Subscribe for More Information
10:56 EDTJNJJohnson & Johnson reports 18% passive stake in Minerva
Subscribe for More Information
05:53 EDTABBVStocks with implied volatility movement; HLF ABBV
Stocks with implied volatility movement; Herbalife (HLF) 52, AbbVie (ABBV) 30 according to iVolatility.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use